Literature DB >> 12163428

Use of the logical analysis of data method for assessing long-term mortality risk after exercise electrocardiography.

Michael S Lauer1, Sorin Alexe, Claire E Pothier Snader, Eugene H Blackstone, Hemant Ishwaran, Peter L Hammer.   

Abstract

BACKGROUND: Logical Analysis of Data is a methodology of mathematical optimization on the basis of the systematic identification of patterns or "syndromes." In this study, we used Logical Analysis of Data for risk stratification and compared it to regression techniques. METHODS AND
RESULTS: Using a cohort of 9454 patients referred for exercise testing, Logical Analysis of Data was applied to identify syndromes based on 20 variables. High-risk syndromes were patterns of up to 3 findings associated with >5-fold increase in risk of death, whereas low-risk syndromes were associated with >5-fold decrease. Syndromes were derived on a randomly derived training set of 4722 patients and validated in 4732 others. There were 15 high-risk and 26 low-risk syndromes. A risk score was derived based on the proportion of possible high risk and low risk syndromes present. A value > or =0, meaning the same or a greater proportion of high-risk syndromes, was noted in 979 patients (21%) in the validation set and was predictive of 5-year death (11% versus 1%, hazard ratio 8.3, 95% CI 5.9 to 11.6, P<0.0001), accounting for 67% of events. Calibration of expected versus observed death rates based on Logical Analysis of Data and Cox regression showed that both methods performed very well.
CONCLUSION: Using the Logical Analysis of Data method, we identified subsets of patients who had an increased risk and who also accounted for the majority of deaths. Future research is needed to determine how best to use this technique for risk stratification.

Entities:  

Mesh:

Year:  2002        PMID: 12163428     DOI: 10.1161/01.cir.0000024410.15081.fd

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Novel analytical methods applied to type 1 diabetes genome-scan data.

Authors:  Flemming Pociot; Allan E Karlsen; Claus B Pedersen; Mogens Aalund; Jørn Nerup
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

2.  High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data.

Authors:  Sophie Grivaud Martin; Louis-Philippe Kronek; Dominique Valeyre; Nadia Brauner; Pierre-Yves Brillet; Hilario Nunes; Michel W Brauner; Frédérique Réty
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

3.  Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death.

Authors:  Marie-Luise Brennan; Anupama Reddy; W H Wilson Tang; Yuping Wu; Danielle M Brennan; Amy Hsu; Shirley A Mann; Peter L Hammer; Stanley L Hazen
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

4.  Breast cancer prognosis by combinatorial analysis of gene expression data.

Authors:  Gabriela Alexe; Sorin Alexe; David E Axelrod; Tibérius O Bonates; Irina I Lozina; Michael Reiss; Peter L Hammer
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

5.  A Classification Model to Predict the Rate of Decline of Kidney Function.

Authors:  Ersoy Subasi; Munevver Mine Subasi; Peter L Hammer; John Roboz; Victor Anbalagan; Michael S Lipkowitz
Journal:  Front Med (Lausanne)       Date:  2017-07-19

6.  Detecting disease-associated genotype patterns.

Authors:  Quan Long; Qingrun Zhang; Jurg Ott
Journal:  BMC Bioinformatics       Date:  2009-01-30       Impact factor: 3.169

7.  Logical Analysis of Data (LAD) model for the early diagnosis of acute ischemic stroke.

Authors:  Anupama Reddy; Honghui Wang; Hua Yu; Tiberius O Bonates; Vimla Gulabani; Joseph Azok; Gerard Hoehn; Peter L Hammer; Alison E Baird; King C Li
Journal:  BMC Med Inform Decis Mak       Date:  2008-07-10       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.